Cargando…

Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?

Polygenic autoinflammatory diseases (AIDs), such as systemic juvenile idiopathic arthritis (sJIA), adult-onset Still's disease, Kawasaki disease, idiopathic recurrent pericarditis (IRP), Behçet’s Syndrome, Crystal-induced arthropatihes such as gout or Calcium pyrophosphate deposition disease ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malcova, Hana, Milota, Tomas, Strizova, Zuzana, Cebecauerova, Dita, Striz, Ilja, Sediva, Anna, Horvath, Rudolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941751/ https://www.ncbi.nlm.nih.gov/pubmed/33708123 http://dx.doi.org/10.3389/fphar.2020.619273

Ejemplares similares

IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives
por: Malcova, Hana, et al.
Publicado: (2021)

Increased histone citrullination in juvenile idiopathic arthritis
por: Parackova, Zuzana, et al.
Publicado: (2022)

Expanded population of low-density neutrophils in juvenile idiopathic arthritis
por: Parackova, Zuzana, et al.
Publicado: (2023)

Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab
por: Smetanova, Jitka, et al.
Publicado: (2022)

Two phenotypes of chronic recurrent multifocal osteomyelitis with different patterns of bone involvement
por: Cebecauerová, Dita, et al.
Publicado: (2022)

Polygenic risk scores for complex diseases: where are we now?
por: Loh, Marie, et al.
Publicado: (2023)

M1/M2 macrophages and their overlaps – myth or reality?
por: Strizova, Zuzana, et al.
Publicado: (2023)

New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
por: Striz, Ilja, et al.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs
por: Smetanova, Jitka, et al.
Publicado: (2022)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

β-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now?
por: Pathak, Atul, et al.
Publicado: (2021)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Personal workstations: Where are we now?
por: Willers, Ian Malcolm
Publicado: (1982)

Personal genomics: Where are we now?
por: Angrist, Misha
Publicado: (2016)

9. GFR - Where are We Now?
por: Delanghe, Joris R.
Publicado: (2009)

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

Intracranial Atherosclerosis: Where Are We Now?
por: Kim, Jong S.
Publicado: (2017)

Mindfulness in psychiatry – where are we now?
por: Groves, Paramabandhu
Publicado: (2016)

MHC Restriction: Where Are We Now?
por: Zareie, Pirooz, et al.
Publicado: (2020)

Microbiota and Obesity: Where Are We Now?
por: Ballini, Andrea, et al.
Publicado: (2020)

Pegfilgrastim Biosimilars: Where Are We Now?
por: Selby, Christopher, et al.
Publicado: (2021)

Hepatocellular adenoma: Where are we now?
por: Wang, Xi, et al.
Publicado: (2022)

Osteopontin and Transplantation: Where Are We Now?
por: Kaleta, Beata
Publicado: (2021)

Epilepsy and psychosis– where are we now?
por: Pereira, I., et al.
Publicado: (2021)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

Crop Improvement: Where Are We Now?
por: Sourdille, Pierre, et al.
Publicado: (2022)

Genetics of migraine: where are we now?
por: Grangeon, Lou, et al.
Publicado: (2023)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_jenrqqvk20uspnu4p6il4qt5ag